Skip to main content

News

Nobel Prize goes for $4.8 million at auction

Dr James Watson, of Watson and Crick double-stranded DNA fame, has offered up his Nobel prize for auction, with the intention of donating the proceeds to medical institutions which he says has nurtured him, and scores of others, during his career.

Specialty Drugs to Cost Consumers More Next Year

The patients out of pocket costs for  "Specialty Drugs" will increase significantly in 2015.

NIH Accelerating Medicines Partnership has awarded 10 US centers grants to study Rheumatoid Arthritis and Lupus

In September 2014, the participating members of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Program funded a research Network to implement the program.

Turmeric vs. Ibuprofen: Which is Better for Arthritis?

Ibuprofen has a corner on the over-the-counter pain market, accounting for one-third of OTC analgesics in the U.S.

Dynamic Duo Takes Out The Cellular Trash

Salk scientists identify how immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies.

RoActemra wins EU approval for early RA

Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis.

The Safety of Restarting Infliximab After a Long Drug-Free Hiatus

Restarting infliximab therapy after a drug holiday is safe and effective for patients with inflammatory bowel disease (IBD), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological

×